Improving Health Outcomes in the Cirrhotic Patient

Welcome!

Thank you for participating in the Improving Health Outcomes in the Cirrhotic Patient provided by the Chronic Liver Disease Foundation.

Please select “Register/Take Course” to complete the following:

  • Pre-Test
  • Post-Test
  • Program Evaluation

Upon completion, you will receive your accreditation certificate.

Target Audience

The series will reach targeted health care professionals, including gastroenterologists, hepatologists, advanced practice providers (APPs), managed health care specialists, primary care physicians (PCPs), and hospitalists.

Learning Objectives

  • Discuss the impact of cirrhosis and HE on patient care in the managed health care setting.
  • Determine the core issues affecting the positive and negative health outcomes of cirrhosis in managed health care.
Course summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 AMA PRA Category 1 Credit™ (Non- MD)
Course opens: 
08/24/2022
Course expires: 
10/31/2023
Rating: 
5

Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the New Mexico Medical Society (NMMS) through the joint providership of Rehoboth McKinley Christian Health Care Services (RMCHCS) and the Chronic Liver Disease Foundation (CLDF). RMCHCS is accredited by the NMMS to provide continuing medical education for physicians.

Credit Designation

RMCHCS designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure of Conflicts of Interest

All faculty, staff, and reviewers involved in the planning, review, or presentation of continuing education activities sponsored/provided by Rehoboth McKinley Christian Health Care Services (RMCHCS) are required to disclose to the audience any relevant commercial financial affiliations related to the content of the presentation and/or enduring material. 

Full disclosure of all commercial relationships must be made in writing to the audience prior to the activity. Note that all relevant financial relationships, if any, have been mitigated. All additional planning committee members, staff, and reviewers of Rehoboth McKinley Christian Health Care Services (RMCHCS) and the Chronic Liver Disease Foundation (CLDF) have no relationships to disclose

This program is supported by an educational grant from Salix Pharmaceuticals.

Accredited by:

Available Credit

  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 AMA PRA Category 1 Credit™ (Non- MD)
Please login or register to take this course.